Search research articles
Contact Us
Filters
Showing results (101-110 of 110) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 110 results.
Allergy
|
March 29, 2025
Clinical, Epidemiological, Virological Characteristics and Outcomes of 286 Patients Infected With Monkeypox Virus in China
Hankun Hu, Yang Zheng, Lianguo Ruan, et al.
Frontiers in Pharmacology
|
January 11, 2020
Six-Year Immunologic Recovery and Virological Suppression of HIV Patients on LPV/r-Based Second-Line Antiretroviral Treatment: A Multi-Center Real-World Cohort Study in China
Xiaojie Huang, Liumei Xu, Lijun Sun, et al.
Journal of Thoracic Disease
|
December 7, 2020
Comparison of clinical characteristics between patients with coronavirus disease 2019 (COVID-19) who retested RT-PCR positive versus negative: a retrospective study of data from Nanjing
Yuan Liu, Ning Ding, Shixiang Zhou, et al.
The Lancet Regional Health. Western Pacific
|
June 7, 2023
(5R)-5-hydroxytriptolide for HIV immunological non-responders receiving ART: a randomized, double-blinded, placebo-controlled phase II study
Wei Cao, Xiaosheng Liu, Yang Han, et al.
Infectious Diseases of Poverty
|
August 14, 2023
Immediate and long-term outcomes after treat-all among people living with HIV in China: an interrupted time series analysis
Xinsheng Wu, Guohui Wu, Ping Ma, et al.
The Lancet Regional Health. Western Pacific
|
August 7, 2023
Efficacy and safety of ainuovirine versus efavirenz combination therapies with lamivudine/tenofovir disoproxil fumarate for medication of treatment-naïve HIV-1-positive adults: week 48 results of a randomized controlled phase 3 clinical trial followed by an open-label setting until week 96
Bin Su, Guiju Gao, Min Wang, et al.
Scientific Reports
|
June 18, 2017
Burden of sleep disturbances and associated risk factors: A cross-sectional survey among HIV-infected persons on antiretroviral therapy across China
Xiaojie Huang, Huiqin Li, Kathrine Meyers, et al.
Nature Communications
|
August 13, 2024
Highly potent and broadly neutralizing anti-CD4 trimeric nanobodies inhibit HIV-1 infection by inducing CD4 conformational alteration
Linjing Zhu, Bilian Huang, Xiangyao Wang, et al.
The Lancet Regional Health. Western Pacific
|
August 15, 2022
The impact of COVID-19 non-pharmaceutical interventions on HIV care continuum in China: An interrupted time series analysis
Xinsheng Wu, Guohui Wu, Yanmin Ma, et al.
Science Translational Medicine
|
November 19, 2025
A rationally designed cocktail of nanobodies elicited by heterologous vaccination confers protection against SFTSV in preclinical models
Xilin Wu, Linjing Zhu, Shengjian Liang, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 110) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 110 results.
Allergy
|
March 29, 2025
Clinical, Epidemiological, Virological Characteristics and Outcomes of 286 Patients Infected With Monkeypox Virus in China
Hankun Hu, Yang Zheng, Lianguo Ruan, et al.
Frontiers in Pharmacology
|
January 11, 2020
Six-Year Immunologic Recovery and Virological Suppression of HIV Patients on LPV/r-Based Second-Line Antiretroviral Treatment: A Multi-Center Real-World Cohort Study in China
Xiaojie Huang, Liumei Xu, Lijun Sun, et al.
Journal of Thoracic Disease
|
December 7, 2020
Comparison of clinical characteristics between patients with coronavirus disease 2019 (COVID-19) who retested RT-PCR positive versus negative: a retrospective study of data from Nanjing
Yuan Liu, Ning Ding, Shixiang Zhou, et al.
The Lancet Regional Health. Western Pacific
|
June 7, 2023
(5R)-5-hydroxytriptolide for HIV immunological non-responders receiving ART: a randomized, double-blinded, placebo-controlled phase II study
Wei Cao, Xiaosheng Liu, Yang Han, et al.
Infectious Diseases of Poverty
|
August 14, 2023
Immediate and long-term outcomes after treat-all among people living with HIV in China: an interrupted time series analysis
Xinsheng Wu, Guohui Wu, Ping Ma, et al.
The Lancet Regional Health. Western Pacific
|
August 7, 2023
Efficacy and safety of ainuovirine versus efavirenz combination therapies with lamivudine/tenofovir disoproxil fumarate for medication of treatment-naïve HIV-1-positive adults: week 48 results of a randomized controlled phase 3 clinical trial followed by an open-label setting until week 96
Bin Su, Guiju Gao, Min Wang, et al.
Scientific Reports
|
June 18, 2017
Burden of sleep disturbances and associated risk factors: A cross-sectional survey among HIV-infected persons on antiretroviral therapy across China
Xiaojie Huang, Huiqin Li, Kathrine Meyers, et al.
Nature Communications
|
August 13, 2024
Highly potent and broadly neutralizing anti-CD4 trimeric nanobodies inhibit HIV-1 infection by inducing CD4 conformational alteration
Linjing Zhu, Bilian Huang, Xiangyao Wang, et al.
The Lancet Regional Health. Western Pacific
|
August 15, 2022
The impact of COVID-19 non-pharmaceutical interventions on HIV care continuum in China: An interrupted time series analysis
Xinsheng Wu, Guohui Wu, Yanmin Ma, et al.
Science Translational Medicine
|
November 19, 2025
A rationally designed cocktail of nanobodies elicited by heterologous vaccination confers protection against SFTSV in preclinical models
Xilin Wu, Linjing Zhu, Shengjian Liang, et al.
Page
of 11